Skip to main content
Side panel
More
You are currently using guest access
Log in
Home
M410- Clinical Research Study Management and Compliance (CRSMC)- Fall 2025
Slides for Week 4: Investigational New Drug and Data & Safety Monitoring Committees
Slides for Week 4: Investigational New Drug and Data & Safety Monitoring Committees
Dr. Alan Ho's slides on INDC
Click
Week 04- Ho [INDC]- CRSMC- Fall 2025.pdf
link to view the file.
◄ Questions for Session 4
Jump to...
Jump to...
Syllabus for M410- Clinical Research Study Management and Compliance (CRSMC)- Fall 2025
Questions for Session 1
Recording for Session 1: Introduction to Clinical Research Implementation and Management
Slides for Session 1: Introduction to Clinical Research Implementation and Management
Questions for Session 2
Recording for Session 2: Human Subjects Protection
Slides for Week 2: Human Subjects Protection
Questions for Session 3
Slides for Session 3: The Scientific Protocol Review Process at MSK and other NCI Designated Cancer Centers
Recording for Session 3: The Scientific Protocol Review Process at MSK and other NCI Designated Cancer Centers
Questions for Session 4
Slides for Week 4: Investigational New Drug and Data & Safety Monitoring Committees
Recording for Week 4: Investigational New Drug and Data & Safety Monitoring Committees
Questions for Session 5
Recording for Session 5: Logistics of Enrolling Patients – Reducing Barriers to Clinical Trials
Slides for Session 5- Logistics of Enrolling Patients – Reducing Barriers to Clinical Trials
Article #1- How do doctors explain randomised clinical trials to their patients?
Article #2- Power of an Effective Clinical Conversation: Improving Accrual Onto Clinical Trials
Questions for Session 6
Recording for Session 6: Subject Safety (2021 Lecture)
Slides for Week 6: Subject Safety (2021 Lecture)
Questions for Session 7
Slides for Session 7: Sponsor – Investigator Relationships and Responsibilities (Riely)
Slides for Session 7: Sponsor – Investigator Relationships and Responsibilities (McCarthy)
Recording for Session 7: Sponsor – Investigator Relationships and Responsibilities
Questions for Session 8
Slides for Session 8- The Patient’s Perspective
Recording for Session 8- The Patient’s Perspective
Questions for Session 9
Slides for Session 9: Securing Multidisciplinary Support and Multimodality Studies
Recording for Session 9: Securing Multidisciplinary Support and Multimodality Studies
Questions for Session 10
Questions for Session 11
Questions for Session 12
Questions for Session 13
Questions for Session 14
Questions for Session 15
Slides for Week 4: Investigational New Drug and Data & Safety Monitoring Committees ►